Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy
J Eur Acad Dermatol Venereol
.
2021 Sep;35(9):e548-e551.
doi: 10.1111/jdv.17343.
Epub 2021 Jun 7.
Authors
E Farinazzo
1
,
G Ponis
2
,
E Zelin
1
,
E Errichetti
3
,
G Stinco
3
,
C Pinzani
4
,
A Gambelli
5
,
N De Manzini
6
,
L Toffoli
1
,
A Moret
1
,
M Agozzino
1
,
C Conforti
1
,
N Di Meo
1
,
P Schincariol
2
,
I Zalaudek
1
Affiliations
1
Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.
2
Hospital Pharmacy Unit, Cattinara Hospital, Trieste, Italy.
3
Department of Medical Area, Institute of Dermatology, University of Udine, Udine, Italy.
4
Dermatology and Venereology, Private Practice, Udine, Italy.
5
Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, National Cancer Institute, Aviano, Italy.
6
UCO Chirurgia Generale, Cattinara Hospital, University of Trieste, Trieste, Italy.
PMID:
34021625
PMCID:
PMC8242497
DOI:
10.1111/jdv.17343
No abstract available
Publication types
Letter
MeSH terms
Administration, Cutaneous
COVID-19 Vaccines*
COVID-19*
Humans
Italy
RNA
SARS-CoV-2
Substances
COVID-19 Vaccines
RNA